Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ResolveMass Laboratories is a specialized contract research organization (CRO) providing advanced mass spectrometry services for the biopharmaceutical industry. The company leverages native mass spectrometry to provide high-resolution characterization of complex biotherapeutics, including monoclonal antibodies, bispecifics, and antibody-drug conjugates. Their expertise extends to the analysis of viral vectors, such as AAV capsids, and membrane proteins using proprietary technologies. By delivering detailed structural and purity data, ResolveMass supports drug discovery, formulation development, and quality control for its clients. The company is a spin-out from the University of Arizona, building on pioneering research in analytical chemistry and deconvolution software. ResolveMass serves as a critical partner for biotechnology companies seeking to understand the molecular complexity of their therapeutic candidates.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ResolveMass Laboratories.